Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01672242 · ClinicalTrials.gov registry record · NA
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
A NA study of Healthy Adult Volunteers, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01672242 is a NA study of Healthy Adult Volunteers that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 6 participants, below the 22-participant average among 4 other Healthy Adult Volunteers trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01672242, a NA study of Healthy Adult Volunteers, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Respiratory distress is a common problem in an intensive care unit. There are multiple mechanisms that are used to help patients who are in respiratory distress including mechanical ventilation, continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), high flow oxygen, and oxygen supplementation through nasal cannula or a facemask. The purpose of this study is to evaluate the mechanism by which Vapotherm, a high flow oxygen system, provides breathing support. Vapotherm provides high flow oxygen at different flow rates, meaning one can increase the amount of oxygen flow to help with breathing support. The investigators believe that this high flow oxygen system may provide similar breathing support that a continuous positive airway pressure machine (CPAP) machine does.
Conditions Studied
Interventions
- DEVICE CPAP
- DEVICE HFNC
Study Locations (1)
Maryland
- University of Maryland School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01672242
The ClinicalTrials.gov registry entry for NCT01672242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 22-participant average among 4 other Healthy Adult Volunteers trials with a reported enrollment target (73% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Adult Volunteers appearing as the primary indexed condition, and to 2 interventions - of which CPAP is the first listed.
NCT01672242 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01672242 about?
NCT01672242 is a clinical study titled "Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)". Respiratory distress is a common problem in an intensive care unit. There are multiple mechanisms that are used to help patients who are in respiratory distress including mechanical ventilation, continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), high flow oxygen, a...
What is the current status of trial NCT01672242?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2012-07. Estimated completion is 2014-04.
What conditions does trial NCT01672242 study?
This clinical trial studies the following conditions: Healthy Adult Volunteers.
What interventions are being tested in trial NCT01672242?
The interventions under investigation include: CPAP (DEVICE), HFNC (DEVICE).
Who is sponsoring clinical trial NCT01672242?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01672242 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Dextromethorphan in Healthy Adult Subjects
COMPLETED · Phase 1
-
4-methylpyrazole and Acetaminophen Metabolism
COMPLETED · Early Phase 1
-
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120
COMPLETED · Phase 1
-
A MAD Study of TT301/MW189 in Healthy Volunteers
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.